Rockefeller Financial Services’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | $49.7M | Buy |
132,164
+8,752
| +7% | +$3.29M | 0.78% | 38 |
|
|
2017
Q3 | $55.2M | Sell |
123,412
-95
| -0.1% | -$42.5K | 1.05% | 31 |
|
|
2017
Q2 | $60.7M | Sell |
123,507
-44,113
| -26% | -$21.7M | 1.2% | 30 |
|
|
2017
Q1 | $65M | Buy |
167,620
+19,275
| +13% | +$7.47M | 1.3% | 28 |
|
|
2016
Q4 | $54.5M | Buy |
148,345
+60,470
| +69% | +$22.2M | 1.11% | 32 |
|
|
2016
Q3 | $35.3M | Sell |
87,875
-4,095
| -4% | -$1.65M | 0.74% | 43 |
|
|
2016
Q2 | $32.1M | Sell |
91,970
-46,185
| -33% | -$16.1M | 0.64% | 43 |
|
|
2016
Q1 | $49.8M | Buy |
138,155
+31,946
| +30% | +$11.5M | 0.97% | 39 |
|
|
2015
Q4 | $57.7M | Sell |
106,209
-49,248
| -32% | -$26.7M | 1.12% | 35 |
|
|
2015
Q3 | $72.3M | Buy |
155,457
+10,528
| +7% | +$4.9M | 1.47% | 25 |
|
|
2015
Q2 | $73.9M | Buy |
144,929
+57,317
| +65% | +$29.2M | 1.53% | 25 |
|
|
2015
Q1 | $39.6M | Buy |
87,612
+2,974
| +4% | +$1.34M | 0.85% | 35 |
|
|
2014
Q4 | $34.7M | Sell |
84,638
-3,174
| -4% | -$1.3M | 0.76% | 40 |
|
|
2014
Q3 | $31.7M | Sell |
87,812
-22,568
| -20% | -$8.14M | 0.71% | 44 |
|
|
2014
Q2 | $31.2M | Sell |
110,380
-47,282
| -30% | -$13.4M | 0.7% | 46 |
|
|
2014
Q1 | $47.3M | Buy |
157,662
+129
| +0.1% | +$38.7K | 1.03% | 36 |
|
|
2013
Q4 | $43.4M | Sell |
157,533
-86,314
| -35% | -$23.8M | 0.94% | 38 |
|
|
2013
Q3 | $76.3M | Sell |
243,847
-23,532
| -9% | -$7.36M | 1.77% | 8 |
|
|
2013
Q2 | $60.1M | Buy |
+267,379
| New | +$60.1M | 1.44% | 17 |
|